Propanc Biopharma, Inc. (PPCB)
1.76
-0.12
(-6.38%)
USD |
NASDAQ |
Nov 18, 16:00
1.77
+0.01
(+0.57%)
After-Hours: 20:00
Propanc Biopharma Price to Book Value : 0.2448 for Nov. 18, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 18, 2026 | 0.2448 |
| November 17, 2026 | 0.2615 |
| November 16, 2026 | 0.2629 |
| November 13, 2026 | 0.27 |
| November 12, 2026 | 0.267 |
| November 11, 2026 | 0.2559 |
| November 10, 2026 | 0.242 |
| November 09, 2026 | 0.2448 |
| November 06, 2026 | 0.2462 |
| November 05, 2026 | 0.2281 |
| November 04, 2026 | 0.249 |
| November 03, 2026 | 0.2378 |
| November 02, 2026 | 0.2392 |
| October 30, 2026 | 0.2559 |
| October 29, 2026 | 0.2935 |
| October 28, 2026 | 0.2935 |
| October 27, 2026 | 0.338 |
| October 26, 2026 | 0.3185 |
| October 23, 2026 | 0.3894 |
| October 22, 2026 | 0.3811 |
| October 21, 2026 | 0.4387 |
| October 20, 2026 | 0.4465 |
| October 19, 2026 | 0.0441 |
| October 16, 2026 | 0.0476 |
| October 15, 2026 | 0.0475 |
| Date | Value |
|---|---|
| October 14, 2026 | 0.0509 |
| October 13, 2026 | 0.0574 |
| October 12, 2026 | 0.0612 |
| October 09, 2026 | 0.0676 |
| October 08, 2026 | 0.0655 |
| October 07, 2026 | 0.0694 |
| October 06, 2026 | 0.0683 |
| October 05, 2026 | 0.0695 |
| October 02, 2026 | 0.0706 |
| October 01, 2026 | 0.0697 |
| September 30, 2026 | 0.0687 |
| September 29, 2026 | 0.1804 |
| September 28, 2026 | 0.1878 |
| September 25, 2026 | 0.222 |
| September 24, 2026 | 0.2119 |
| September 23, 2026 | 0.2211 |
| September 22, 2026 | 0.2292 |
| September 21, 2026 | 0.2217 |
| September 18, 2026 | 0.2148 |
| September 17, 2026 | 0.2219 |
| September 16, 2026 | 0.2236 |
| September 15, 2026 | 0.2888 |
| September 14, 2026 | 0.2993 |
| September 11, 2026 | 0.3243 |
| September 10, 2026 | 0.332 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Immutep Ltd. | -- |
| CSL Ltd. | -- |
| Ceryvyn Therapeutics Ltd. | -- |
| Mesoblast Ltd. | 1.990 |
| Actinogen Medical Ltd. | -- |
Price to Book Value Related Metrics
| Price | 1.76 |
| Earnings Yield | -1.60K% |
| Market Cap | 1.731M |